BIOGEN INC. Amortization of Intangible Assets
BIOGEN INC. (BIIB) reported Amortization of Intangible Assets of $507.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-02-06
- BIOGEN INC. amortization of intangible assets for the quarter ending 2025-12-31 was $132.20M, a 18.88% increase year-over-year.
- BIOGEN INC. amortization of intangible assets for the quarter ending 2025-09-30 was $135.70M, a 23.25% increase year-over-year.
- BIOGEN INC. amortization of intangible assets for the quarter ending 2025-06-30 was $127.40M, a 46.61% increase year-over-year.
- BIOGEN INC. amortization of intangible assets for the quarter ending 2025-03-31 was $111.80M.
- BIOGEN INC. amortization of intangible assets for fiscal 2025 was $507.10M, a 31.20% increase from fiscal 2024.
- BIOGEN INC. amortization of intangible assets for fiscal 2024 was $386.50M, a 60.64% increase from fiscal 2023.
- BIOGEN INC. amortization of intangible assets for fiscal 2023 was $240.60M, a 2.31% decline from fiscal 2022.
- BIOGEN INC. amortization of intangible assets for fiscal 2022 was $246.30M, a 2.26% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $132.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $267.90M derived: sum of 2 quarters · filed 2026-02-06 | $395.30M derived: sum of 3 quarters · filed 2026-02-06 | $507.10M 10-K · filed 2026-02-06 | ||||
| 2025-09-30 | $135.70M 10-Q · filed 2025-10-30 | $263.10M derived: sum of 2 quarters · filed 2025-10-30 | $374.90M 10-Q · filed 2025-10-30 | $486.10M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2025-06-30 | $127.40M 10-Q · filed 2025-07-31 | $239.20M 10-Q · filed 2025-07-31 | $350.40M derived: sum of 3 quarters · filed 2026-02-06 | $460.50M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2025-03-31 | $111.80M derived: 10-K 12 month − 3 quarters · filed 2026-02-06 | $223.00M derived: sum of 2 quarters · filed 2026-02-06 | $333.10M derived: sum of 3 quarters · filed 2026-02-06 | $420.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-12-31 | $111.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $221.30M derived: sum of 2 quarters · filed 2026-02-06 | $308.20M derived: sum of 3 quarters · filed 2026-02-06 | $386.50M 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $110.10M 10-Q · filed 2025-10-30 | $197.00M derived: sum of 2 quarters · filed 2025-10-30 | $275.30M 10-Q · filed 2025-10-30 | |||||
| 2024-06-30 | $86.90M 10-Q · filed 2025-07-31 | $165.20M 10-Q · filed 2025-07-31 | ||||||
| 2023-12-31 | $240.60M 10-K · filed 2026-02-06 | |||||||
| 2022-12-31 | $246.30M 10-K · filed 2025-02-12 | |||||||
| 2021-12-31 | $252.00M 10-K · filed 2024-02-14 | |||||||
| 2020-12-31 | $58.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $122.10M derived: sum of 2 quarters · filed 2023-02-15 | $183.60M derived: sum of 3 quarters · filed 2023-02-15 | $255.10M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $63.30M 10-Q · filed 2020-10-21 | $124.80M derived: sum of 2 quarters · filed 2020-10-21 | $196.30M 10-Q · filed 2020-10-21 | $264.00M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $61.50M 10-Q · filed 2020-07-22 | $133.00M 10-Q · filed 2020-07-22 | $200.70M derived: sum of 3 quarters · filed 2022-02-03 | $268.70M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | $71.50M 10-Q · filed 2020-04-23 | $139.20M derived: sum of 2 quarters · filed 2022-02-03 | $207.20M derived: sum of 3 quarters · filed 2022-02-03 | $277.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $67.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $135.70M derived: sum of 2 quarters · filed 2022-02-03 | $205.80M derived: sum of 3 quarters · filed 2022-02-03 | $274.00M 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $68.00M 10-Q · filed 2020-10-21 | $283.90M 10-Q · filed 2019-10-22 | $138.10M derived: sum of 2 quarters · filed 2020-10-21 | $206.30M 10-Q · filed 2020-10-21 | $422.20M 10-Q · filed 2019-10-22 | $94.30M derived: sum of 4 quarters · filed 2021-02-03 | ||
| 2019-06-30 | $70.10M 10-Q · filed 2020-07-22 | $138.30M 10-Q · filed 2020-07-22 | $26.30M derived: sum of 3 quarters · filed 2021-02-03 | $308.20M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $68.20M 10-Q · filed 2020-04-23 | -$43.80M derived: sum of 2 quarters · filed 2021-02-03 | $238.10M derived: sum of 3 quarters · filed 2021-02-03 | $345.50M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | $169.90M derived: sum of 2 quarters · filed 2021-02-03 | $277.30M derived: sum of 3 quarters · filed 2021-02-03 | $381.20M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | $281.90M 10-Q · filed 2019-10-22 | $389.30M derived: sum of 2 quarters · filed 2019-10-22 | $493.20M 10-Q · filed 2019-10-22 | $273.60M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $107.40M 10-Q · filed 2019-07-24 | $211.30M 10-Q · filed 2019-07-24 | -$8.30M derived: sum of 3 quarters · filed 2020-02-06 | $100.60M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | $103.90M 10-Q · filed 2019-04-24 | -$115.70M derived: sum of 2 quarters · filed 2020-02-06 | -$6.80M derived: sum of 3 quarters · filed 2020-02-06 | $110.70M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | -$219.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | -$110.70M derived: sum of 2 quarters · filed 2020-02-06 | $6.80M derived: sum of 3 quarters · filed 2020-02-06 | $455.30M 10-K · filed 2020-02-06 | $814.70M 10-K · filed 2018-02-01 | |||
| 2017-09-30 | $108.90M 10-Q · filed 2018-10-23 | $226.40M derived: sum of 2 quarters · filed 2018-10-23 | $674.90M 10-Q · filed 2018-10-23 | $766.90M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $117.50M 10-Q · filed 2018-07-24 | $566.00M 10-Q · filed 2018-07-24 | $658.00M derived: sum of 3 quarters · filed 2019-02-06 | $757.70M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | $448.50M 10-Q · filed 2018-04-24 | $540.50M derived: sum of 2 quarters · filed 2019-02-06 | $640.20M derived: sum of 3 quarters · filed 2019-02-06 | $733.10M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | $191.70M derived: sum of 2 quarters · filed 2019-02-06 | $284.60M derived: sum of 3 quarters · filed 2019-02-06 | $373.40M 10-K · filed 2019-02-06 | $385.60M 10-K · filed 2017-02-02 | |||
| 2016-09-30 | $99.70M 10-Q · filed 2017-10-24 | $192.60M derived: sum of 2 quarters · filed 2017-10-24 | $281.40M 10-Q · filed 2017-10-24 | $378.00M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | $92.90M 10-Q · filed 2017-07-25 | $181.70M 10-Q · filed 2017-07-25 | $278.30M derived: sum of 3 quarters · filed 2018-02-01 | $376.40M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | $88.80M 10-Q · filed 2017-04-25 | $185.40M derived: sum of 2 quarters · filed 2018-02-01 | $283.50M derived: sum of 3 quarters · filed 2018-02-01 | $375.50M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | $96.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $194.70M derived: sum of 2 quarters · filed 2018-02-01 | $286.70M derived: sum of 3 quarters · filed 2018-02-01 | $382.60M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $98.10M 10-Q · filed 2016-10-26 | $98.06M 10-Q · filed 2015-10-21 | $190.10M derived: sum of 2 quarters · filed 2016-10-26 | $286.00M 10-Q · filed 2016-10-26 | $285.97M 10-Q · filed 2015-10-21 | $393.29M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | $92.00M 10-Q · filed 2016-07-21 | $92.00M 10-Q · filed 2015-07-24 | $187.90M 10-Q · filed 2016-07-21 | $187.91M 10-Q · filed 2015-07-24 | $295.19M derived: sum of 3 quarters · filed 2017-02-02 | $417.62M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | $95.90M 10-Q · filed 2016-04-21 | $95.90M 10-Q · filed 2015-04-24 | $203.19M derived: sum of 2 quarters · filed 2017-02-02 | $325.62M derived: sum of 3 quarters · filed 2017-02-02 | $442.44M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | $107.28M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | $229.72M derived: sum of 2 quarters · filed 2017-02-02 | $346.54M derived: sum of 3 quarters · filed 2017-02-02 | $489.80M 10-K · filed 2017-02-02 | $489.76M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | $122.43M 10-Q · filed 2015-10-21 | $239.26M derived: sum of 2 quarters · filed 2015-10-21 | $382.51M 10-Q · filed 2015-10-21 | $491.89M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $116.83M 10-Q · filed 2015-07-24 | $260.08M 10-Q · filed 2015-07-24 | $369.46M derived: sum of 3 quarters · filed 2016-02-03 | $469.46M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | $143.26M 10-Q · filed 2015-04-24 | $252.63M derived: sum of 2 quarters · filed 2016-02-03 | $352.63M derived: sum of 3 quarters · filed 2016-02-03 | $434.86M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $109.38M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $209.37M derived: sum of 2 quarters · filed 2016-02-03 | $291.60M derived: sum of 3 quarters · filed 2016-02-03 | $342.90M 10-K · filed 2016-02-03 | $342.95M 10-K · filed 2014-02-06 | |||
| 2013-09-30 | $100.00M 10-Q · filed 2014-10-22 | $182.22M derived: sum of 2 quarters · filed 2014-10-22 | $233.52M 10-Q · filed 2014-10-22 | $284.47M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $82.22M 10-Q · filed 2014-07-23 | $133.53M 10-Q · filed 2014-07-23 | $184.47M derived: sum of 3 quarters · filed 2015-02-04 | $237.49M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $51.30M 10-Q · filed 2014-04-23 | $102.25M derived: sum of 2 quarters · filed 2015-02-04 | $155.26M derived: sum of 3 quarters · filed 2015-02-04 | $207.54M derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $50.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $103.96M derived: sum of 2 quarters · filed 2015-02-04 | $156.24M derived: sum of 3 quarters · filed 2015-02-04 | $202.20M 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $53.01M 10-Q · filed 2013-10-28 | $105.30M derived: sum of 2 quarters · filed 2013-10-28 | $151.26M 10-Q · filed 2013-10-28 | $202.12M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $52.28M 10-Q · filed 2013-07-25 | $98.24M 10-Q · filed 2013-07-25 | $149.11M derived: sum of 3 quarters · filed 2014-02-06 | $198.46M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | $45.96M 10-Q · filed 2013-04-25 | $96.83M derived: sum of 2 quarters · filed 2014-02-06 | $146.18M derived: sum of 3 quarters · filed 2014-02-06 | $201.31M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | $50.87M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $100.21M derived: sum of 2 quarters · filed 2014-02-06 | $155.35M derived: sum of 3 quarters · filed 2014-02-06 | $208.57M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $49.35M 10-Q · filed 2012-10-25 | $104.48M derived: sum of 2 quarters · filed 2012-10-25 | $157.70M 10-Q · filed 2012-10-25 | $211.06M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-06-30 | $55.14M 10-Q · filed 2012-07-24 | $108.35M 10-Q · filed 2012-07-24 | $161.71M derived: sum of 3 quarters · filed 2013-02-05 | $215.24M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2011-03-31 | $53.22M 10-Q · filed 2012-05-01 | $106.58M derived: sum of 2 quarters · filed 2013-02-05 | $160.11M derived: sum of 3 quarters · filed 2013-02-05 | $213.25M derived: sum of 4 quarters · filed 2013-02-05 | ||||
| 2010-12-31 | $53.36M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05 | $106.89M derived: sum of 2 quarters · filed 2013-02-05 | $160.04M derived: sum of 3 quarters · filed 2013-02-05 | $208.93M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | $53.53M 10-Q · filed 2011-10-28 | $106.68M derived: sum of 2 quarters · filed 2011-10-28 | $155.57M 10-Q · filed 2011-10-28 | $211.55M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-06-30 | $53.15M 10-Q · filed 2011-07-26 | $102.04M 10-Q · filed 2011-07-26 | $158.02M derived: sum of 3 quarters · filed 2012-02-03 | $209.37M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2010-03-31 | $48.89M 10-Q · filed 2011-04-21 | $104.87M derived: sum of 2 quarters · filed 2012-02-03 | $156.22M derived: sum of 3 quarters · filed 2012-02-03 | $249.45M derived: sum of 4 quarters · filed 2012-02-03 | ||||
| 2009-12-31 | $55.98M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03 | $107.33M derived: sum of 2 quarters · filed 2012-02-03 | $200.56M derived: sum of 3 quarters · filed 2012-02-03 | $289.81M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $51.35M 10-Q · filed 2010-10-26 | $144.58M derived: sum of 2 quarters · filed 2010-10-26 | $233.83M 10-Q · filed 2010-10-26 | $324.46M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-06-30 | $93.23M 10-Q · filed 2010-07-20 | $182.48M 10-Q · filed 2010-07-20 | $273.11M derived: sum of 3 quarters · filed 2011-02-04 | $367.58M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2009-03-31 | $89.25M 10-Q · filed 2010-04-20 | $179.88M derived: sum of 2 quarters · filed 2011-02-04 | $274.34M derived: sum of 3 quarters · filed 2011-02-04 | $347.21M derived: sum of 4 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | $90.63M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $185.09M derived: sum of 2 quarters · filed 2011-02-04 | $257.96M derived: sum of 3 quarters · filed 2011-02-04 | $332.75M 10-K · filed 2011-02-04 | ||||
| 2008-09-30 | $94.46M 10-Q · filed 2009-10-21 | $167.33M derived: sum of 2 quarters · filed 2009-10-21 | $242.11M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $72.87M 10-Q · filed 2009-07-17 | $147.65M 10-Q · filed 2009-07-17 | ||||||
| 2007-12-31 | $257.50M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |